TY - JOUR
T1 - Tunneled Hemodialysis Catheter Tip Design and Risk of Catheter Dysfunction
T2 - An Australian Nationwide Cohort Study
AU - Lazarus, Benjamin
AU - Gallagher, Martin
AU - Coggan, Sarah
AU - Gray, Nicholas A.
AU - Talaulikar, Girish
AU - Kotwal, Sradha
AU - on behalf of the REDUCCTION Investigators
A2 - Polkinghorne, Kevan R.
N1 - Funding Information:
The Reducing the Burden of Dialysis Catheter Complications: A National Approach (REDUCCTION) Trial was supported by NHMRC Partnership grant (APP1103241), Department of Health and Human Services , Victoria, Queensland Health, and 22 other partners contributing in-kind and financial support as detailed in the appendix, including grants from government (Queensland Health, Safer Care Victoria, Medical Research Future Fund, National Health and Medical Research Council , Australia), academic (Monash University), and not-for-profit (ANZDATA Registry, Kidney Health Australia) sources. Dr Kotwal was supported by a MRFF Next Generation TRIP Fellowship (MRF1150335). Dr Lazarus is supported by the NHMRC postgraduate research grant (APP2005174) and Monash Graduate Excellence Scholarship. The funders had no input into the design, conduct or publication of the study.
Publisher Copyright:
© 2023 National Kidney Foundation, Inc.
PY - 2024/4
Y1 - 2024/4
N2 - Rationale & Objective: Hemodialysis catheter dysfunction is an important problem for patients with kidney failure. The optimal design of the tunneled catheter tip is unknown. This study evaluated the association of catheter tip design with the duration of catheter function. Study Design: Observational cohort study using data from the nationwide REDUCCTION trial. Setting & Participants: 4,722 adults who each received hemodialysis via 1 or more tunneled central venous catheters in 37 Australian nephrology services from December 2016 to March 2020. Exposure: Design of tunneled hemodialysis catheter tip, classified as symmetrical, step, or split. Outcome: Time to catheter dysfunction requiring removal due to inadequate dialysis blood flow assessed by the treating clinician. Analytical Approach: Mixed, 3-level accelerated failure time model, assuming a log-normal survival distribution. Secular trends, the intervention, and baseline differences in service, patient, and catheter factors were included in the adjusted model. In a sensitivity analysis, survival times and proportional hazards were compared among participants’ first tunneled catheters. Results: Among the study group, 355 of 3,871 (9.2%), 262 of 1,888 (13.9%), and 38 of 455 (8.4%) tunneled catheters with symmetrical, step, and split tip designs, respectively, required removal due to dysfunction. Step tip catheters required removal for dysfunction at a rate 53% faster than symmetrical tip catheters (adjusted time ratio, 0.47 [95% CI, 0.33-0.67) and 76% faster than split tip catheters (adjusted time ratio, 0.24 [95% CI, 0.11-0.51) in the adjusted accelerated failure time models. Only symmetrical tip catheters had performance superior to step tip catheters in unadjusted and sensitivity analyses. Split tip catheters were infrequently used and had risks of dysfunction similar to symmetrical tip catheters. The cumulative incidence of other complications requiring catheter removal, routine removal, and death before removal were similar across the 3 tip designs. Limitations: Tip design was not randomized. Conclusions: Symmetrical and split tip catheters had a lower risk of catheter dysfunction requiring removal than step tip catheters. Funding: Grants from government (Queensland Health, Safer Care Victoria, Medical Research Future Fund, National Health and Medical Research Council, Australia), academic (Monash University), and not-for-profit (ANZDATA Registry, Kidney Health Australia) sources. Trial Registration: Registered at ANZCTR with study number ACTRN12616000830493. Plain-Language Summary: Central venous catheters are widely used to facilitate vascular access for life-sustaining hemodialysis treatments but often fail due to blood clots or other mechanical problems that impede blood flow. A range of adaptations to the design of tunneled hemodialysis catheters have been developed, but it is unclear which designs have the greatest longevity. We analyzed data from an Australian nationwide cohort of patients who received hemodialysis via a tunneled catheter and found that catheters with a step tip design failed more quickly than those with a symmetrical tip. Split tip catheters performed well but were infrequently used and require further study. Use of symmetrical rather than step tip hemodialysis catheters may reduce mechanical failures and unnecessary procedures for patients.
AB - Rationale & Objective: Hemodialysis catheter dysfunction is an important problem for patients with kidney failure. The optimal design of the tunneled catheter tip is unknown. This study evaluated the association of catheter tip design with the duration of catheter function. Study Design: Observational cohort study using data from the nationwide REDUCCTION trial. Setting & Participants: 4,722 adults who each received hemodialysis via 1 or more tunneled central venous catheters in 37 Australian nephrology services from December 2016 to March 2020. Exposure: Design of tunneled hemodialysis catheter tip, classified as symmetrical, step, or split. Outcome: Time to catheter dysfunction requiring removal due to inadequate dialysis blood flow assessed by the treating clinician. Analytical Approach: Mixed, 3-level accelerated failure time model, assuming a log-normal survival distribution. Secular trends, the intervention, and baseline differences in service, patient, and catheter factors were included in the adjusted model. In a sensitivity analysis, survival times and proportional hazards were compared among participants’ first tunneled catheters. Results: Among the study group, 355 of 3,871 (9.2%), 262 of 1,888 (13.9%), and 38 of 455 (8.4%) tunneled catheters with symmetrical, step, and split tip designs, respectively, required removal due to dysfunction. Step tip catheters required removal for dysfunction at a rate 53% faster than symmetrical tip catheters (adjusted time ratio, 0.47 [95% CI, 0.33-0.67) and 76% faster than split tip catheters (adjusted time ratio, 0.24 [95% CI, 0.11-0.51) in the adjusted accelerated failure time models. Only symmetrical tip catheters had performance superior to step tip catheters in unadjusted and sensitivity analyses. Split tip catheters were infrequently used and had risks of dysfunction similar to symmetrical tip catheters. The cumulative incidence of other complications requiring catheter removal, routine removal, and death before removal were similar across the 3 tip designs. Limitations: Tip design was not randomized. Conclusions: Symmetrical and split tip catheters had a lower risk of catheter dysfunction requiring removal than step tip catheters. Funding: Grants from government (Queensland Health, Safer Care Victoria, Medical Research Future Fund, National Health and Medical Research Council, Australia), academic (Monash University), and not-for-profit (ANZDATA Registry, Kidney Health Australia) sources. Trial Registration: Registered at ANZCTR with study number ACTRN12616000830493. Plain-Language Summary: Central venous catheters are widely used to facilitate vascular access for life-sustaining hemodialysis treatments but often fail due to blood clots or other mechanical problems that impede blood flow. A range of adaptations to the design of tunneled hemodialysis catheters have been developed, but it is unclear which designs have the greatest longevity. We analyzed data from an Australian nationwide cohort of patients who received hemodialysis via a tunneled catheter and found that catheters with a step tip design failed more quickly than those with a symmetrical tip. Split tip catheters performed well but were infrequently used and require further study. Use of symmetrical rather than step tip hemodialysis catheters may reduce mechanical failures and unnecessary procedures for patients.
KW - CVC
KW - Dialysis, configuration
KW - failure
KW - malfunction
KW - renal
UR - http://www.scopus.com/inward/record.url?scp=85182372433&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2023.09.021
DO - 10.1053/j.ajkd.2023.09.021
M3 - Article
C2 - 38061534
AN - SCOPUS:85182372433
SN - 0272-6386
VL - 83
SP - 445
EP - 455
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 4
ER -